StockData
BioRestorative Therapies, Inc. logo

BioRestorative Therapies, Inc. (BRTX) shareholders

BRTXNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31
Số liệu tài chính tới Q1 năm tài chính 2026, quý kết thúc ngày Mar 31, 2026Last filing: 10-Q on May 14, 2026Score 8/30
$1.34−0.08 (-5.63%)

Close on Nov 17, 2026Market cap $34.14MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
0.5%
0M of 25M shares
Institutional holders
21
10 new, 0 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Louis Posner
Joint filing with Auctus Fund, LLC (9.90%), Auctus Fund Management LLC (9.90%) and 1 more
2,699,4709.90%13G (passive) amendmentMar 31, 2026
Alstodt Lance1,236,80915.50%13D (active) amendmentFeb 14, 2025
Silva, Francisco1,196,81915.10%13D (active) amendmentFeb 14, 2025
Dale Broadrick926,376–13D (active) amendmentFeb 8, 2024
Alfred Sollami
Joint filing with Auctus Fund Management LLC (9.90%), Auctus Fund, LLC (9.90%) and 1 more
692,4189.90%13G (passive) amendmentSep 30, 2024

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of BRTXValueChange% of portfolio
Jane Street Group, LLC40,1760.16%$302.12KNew0.00%
Hrt Financial LP35,5300.14%$267.00KNew0.00%
XTX Topco Ltd14,3250.06%$107.73KNew0.00%
Citadel Advisors LLC13,6650.05%$102.76K+1,7350.00%
Vanguard Fiduciary Trust Co9,0650.04%$68.17K+7,0920.00%
Geode Capital Management, LLC7,6210.03%$57.31K−3,5340.00%
Citigroup Inc3,1860.01%$23.96KNew0.00%
Wealth Alliance2,0000.01%$15.04K–0.00%
State Street Corp1,6230.01%$12.21K–0.00%
Keystone Financial Group1,4300.01%$10.75KNew0.00%
Northern Trust Corp1,2000.00%$9.03KNew0.00%
Creative Planning1,0870.00%$8.17KNew0.00%
Susquehanna International Group, Llp8030.00%$6.04KNew0.00%
StoneX Group Inc.6950.00%$5.23KNew0.00%
Vanguard Capital Management LLC6490.00%$4.88KNew0.00%
Osaic Holdings, Inc.1000.00%$760–0.00%
Tower Research Capital LLC (TRC)730.00%$550–0.00%
SBI Securities Co., Ltd.350.00%$263+250.00%
UBS Group AG00.00%$0−4,9920.00%
TD Waterhouse Canada Inc.00.00%$1–0.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 2026210M0.5%10 / 32 / 00M0M
Q1 2026110M0.1%3 / 40 / 40M0M
Q4 2025130M0.1%3 / 43 / 40M0M
Q3 2025140M0.1%3 / 51 / 40M0M
Q2 2025150M0.0%2 / 05 / 00M0M
Q1 2025140M0.1%0 / 61 / 10M0M
Q4 2024150M0.1%2 / 33 / 20M0M
Q3 2024150M0.1%4 / 33 / 10M0M
Q2 2024130M0.1%3 / 43 / 30M0M
Q1 2024130M0.1%4 / 33 / 40M0M
Q4 2023130M0.1%3 / 23 / 40M0M
Q3 2023140M0.1%4 / 35 / 30M0M

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Francisco SilvaVP of Research and Development, Director183,5200.72%Oct 20, 2025
Lance AlstodtPresident, CEO, COB, Director, 10% owner187,4970.74%Oct 20, 2025
Robert Eugene KristalChief Financial Officer7,9940.03%Feb 19, 2025
Esha RandhawaDirector––Jul 30, 2026
Steven Collier BrownDirector––Jul 24, 2026
Jatinder DhaliwalDirector––Jun 18, 2026
Mika GrassoDirector––Jun 18, 2026
Katharyn FieldDirector––Jun 17, 2026
Nickolay V. KukekovDirector0–Feb 19, 2025
Patrick F. WilliamsDirector0–Feb 19, 2025
David A. RosaDirector0–Feb 19, 2025

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Francisco Silva
VP of Research and Development, Director
Oct 6, 2025Award+11,719$1.60$18.75K171,384
Lance Alstodt
President, CEO, COB, Director, 10% owner
Oct 6, 2025Award+15,625$1.60$25.00K187,497
Dale Broadrick
10% owner
Oct 28, 2024Sale−1,112$1.58$1.76K445,933
Francisco Silva
VP of Research and Development, Director
Apr 9, 2024Buy+6,600$1.25$8.25K155,759
Francisco Silva
VP of Research and Development, Director
Apr 8, 2024Buy+476$1.13$538147,927
Francisco Silva
VP of Research and Development, Director
Apr 8, 2024Buy+1,232$1.17$1.44K149,159
Lance Alstodt
President, CEO, COB, Director
Mar 18, 2024Tax withholding−17,633$1.39$24.51K171,872
Francisco Silva
VP of Research and Development, Director
Mar 18, 2024Tax withholding−17,193$1.39$23.90K147,451
Dale Broadrick
10% owner
Feb 9, 2024Buy+86,041$1.32$113.57K477,972
Dale Broadrick
10% owner
Feb 8, 2024Buy+73,959$1.25$92.45K391,931
Dale Broadrick
10% owner
Feb 8, 2024Buy+83,626$1.34$112.06K447,045
Dale Broadrick
10% owner
Feb 7, 2024Buy+36,374$1.38$50.20K363,419
Dale Broadrick
10% owner
Dec 1, 2023Sale−250$1.88$470327,045
Dale Broadrick
10% owner
Nov 27, 2023Sale−278$1.89$525327,295
Lance Alstodt
President, CEO, COB, Director, 10% owner
Sep 15, 2023Buy+2,200$1.70$3.74K189,505
Dale Broadrick
10% owner
Sep 15, 2023Buy+10,000$1.66$16.60K327,573
Dale Broadrick
10% owner
Sep 14, 2023Buy+10,000$1.54$15.40K317,573
Lance Alstodt
President, CEO, COB, Director, 10% owner
Sep 13, 2023Buy+800$1.53$1.22K188,105
Dale Broadrick
10% owner
Sep 7, 2023Buy+1,000$1.91$1.91K317,972
Dale Broadrick
10% owner
Sep 7, 2023Buy+1,000$1.81$1.81K307,573
Lance Alstodt
President, CEO, COB, Director, 10% owner
Sep 6, 2023Buy+2,887$1.96$5.66K187,305
Francisco Silva
VP of Research and Development, Director, 10% owner
Aug 31, 2023Buy+4,954$2.22$11.00K164,644
Dale Broadrick
10% owner
Jul 28, 2023Buy+500$2.89$1.45K306,573
Dale Broadrick
10% owner
Jul 27, 2023Buy+1,000$2.80$2.80K306,073
Lance Alstodt
President, CEO, COB, Director, 10% owner
Jul 25, 2023Buy+4,200$2.44$10.25K184,418
Francisco Silva
VP of Research and Development, Director, 10% owner
Mar 31, 2023Buy+747$3.56$2.66K159,690
Lance Alstodt
President, CEO, COB, Director, 10% owner
Mar 20, 2023Tax withholding−6,729$2.92$19.65K180,218
Francisco Silva
VP of Research and Development, Director, 10% owner
Mar 20, 2023Tax withholding−6,729$2.92$19.65K158,943
Dale Broadrick
10% owner
Feb 22, 2023Buy+5,000$2.84$14.20K304,073
Dale Broadrick
10% owner
Feb 22, 2023Buy+1,000$2.95$2.95K305,073
Francisco Silva
VP of Research and Development, Director, 10% owner
Feb 18, 2023Tax withholding−374$2.99$1.12K165,672
Lance Alstodt
President, CEO, COB, Director, 10% owner
Feb 18, 2023Tax withholding−374$2.99$1.12K186,947
Lance Alstodt
President, CEO, COB, Director
Feb 1, 2023Buy+400$3.10$1.24K187,321
Lance Alstodt
President, CEO, COB, Director
Jan 27, 2023Buy+200$3.01$602186,921
Lance Alstodt
President, CEO, COB, Director
Jan 20, 2023Buy+100$3.17$317186,721
Lance Alstodt
President, CEO, COB, Director
Jan 20, 2023Buy+100$3.10$310186,621
Lance Alstodt
President, CEO, COB, Director
Jan 18, 2023Buy+100$3.10$310186,421
Lance Alstodt
President, CEO, COB, Director
Jan 18, 2023Buy+200$3.13$626186,321
Lance Alstodt
President, CEO, COB, Director
Jan 18, 2023Buy+100$3.09$309186,521
Lance Alstodt
President, CEO, COB, Director
Jan 9, 2023Buy+100$3.08$308186,121
Lance Alstodt
President, CEO, COB, Director
Dec 23, 2022Buy+200$3.02$604185,921
Lance Alstodt
President, CEO, COB, Director
Dec 23, 2022Buy+100$2.99$299186,021
Lance Alstodt
President, CEO, COB, Director
Dec 7, 2022Buy+1,800$2.99$5.38K185,721
Dale Broadrick
10% owner
Nov 30, 2022Buy+100$2.78$278298,973
Dale Broadrick
10% owner
Nov 30, 2022Buy+100$2.77$277299,073
Francisco Silva
VP of Research and Development, Director
Nov 21, 2022Buy+943$2.62$2.47K166,046
Lance Alstodt
President, CEO, COB, Director
Nov 18, 2022Buy+1,000$2.88$2.88K183,921
Francisco Silva
VP of Research and Development, Director
Oct 12, 2022Buy+725$3.39$2.46K165,103
Francisco Silva
VP of Research and Development, Director
Oct 11, 2022Buy+806$3.69$2.97K164,378
Dale Broadrick
10% owner
Sep 23, 2022Buy+300$2.83$849298,873
Lance Alstodt
President, CEO, COB, Director
Sep 22, 2022Buy+100$2.85$285182,921
Lance Alstodt
President, CEO, COB, Director
Sep 22, 2022Buy+100$2.99$299182,821
Francisco Silva
VP of Research and Development, Director
Aug 29, 2022Buy+2,816$3.21$9.04K163,572
Francisco Silva
VP of Research and Development, Director
Aug 29, 2022Buy+307$3.32$1.02K12,136
Francisco Silva
VP of Research and Development, Director
Aug 26, 2022Buy+2,600$3.35$8.71K160,756
Francisco Silva
VP of Research and Development, Director
Aug 26, 2022Sale−3,958$3.39$13.42K158,156
Dale Broadrick
10% owner
Jul 13, 2022Buy+200$3.00$600298,573
Dale Broadrick
10% owner
Jul 12, 2022Buy+900$2.97$2.67K298,373
Lance Alstodt
President, CEO, COB, Director
Jul 12, 2022Buy+700$2.95$2.07K182,721
Dale Broadrick
10% owner
Jul 6, 2022Buy+100$3.38$338297,473

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
0.16%
0M shares short
Days to cover
1.0
At 0M shares a day
Change since last report
+146.3%
From 0M shares
Short volume, 20 days
32.5%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of BioRestorative Therapies's stock actually held short. Settlement fails (shares not delivered on time) peaked at 26,810 shares on Sep 4, 2026 over the last 90 days.

See a number that looks wrong?